Emily completed her PhD at Newcastle University, UK, in 2019 under the supervision of Professors Hanns Lochmüller and Clarke Slater. Prior to this she completed an MSci degree during which she examined genetic data from patients and identified a novel causative gene for a subtype of the rare group of diseases Congenital Myasthenic Syndromes (CMS). Subsequently, in her PhD project she researched the role of the gene and its associated protein at the neuromuscular junction. After successfully defending her thesis in June 2019 and obtaining a postdoctoral research fellowship from AFM-Téléthon, she moved to Ottawa to take up a position in the Lochmüller lab. Emily is looking forward to starting new projects aimed toward testing new treatments for CMS and other neuromuscular diseases as part of new collaborations.
